Ribomic Inc.

Tokyo Stock Exchange 4591.T

Ribomic Inc. Free Cash Flow Yield on January 14, 2025: -28.85%

Ribomic Inc. Free Cash Flow Yield is -28.85% on January 14, 2025, a -16.81% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Ribomic Inc. 52-week high Free Cash Flow Yield is -21.91% on August 27, 2024, which is 24.08% above the current Free Cash Flow Yield.
  • Ribomic Inc. 52-week low Free Cash Flow Yield is -35.39% on August 05, 2024, which is -22.66% below the current Free Cash Flow Yield.
  • Ribomic Inc. average Free Cash Flow Yield for the last 52 weeks is -27.88%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Tokyo Stock Exchange: 4591.T

Ribomic Inc.

CEO Mr. Yoshikazu Nakamura Ph.D.
IPO Date Sept. 25, 2014
Location Japan
Headquarters Shirokanedai Usui Building
Employees 24
Sector Health Care
Industries
Pharmaceuticals Biotechnology
Description

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan. The company develops drugs for wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma, as well as separating agents for affinity purification of human IgG and Fc-fusion proteins. Ribomic Inc. was incorporated in 2003 and is headquartered in Tokyo, Japan.

StockViz Staff

January 15, 2025

Any question? Send us an email